Y Combinator is a startup accelerator that invests in a large number of startups twice a year. It created a new model for funding startups. Twice a year, the company invests a small amount of money ($150k) in a large number of startups. The startup accelerator works intensively with the companies for three months, to get them into the best possible shape and refine their pitch to investors. Each cycle culminates in Demo Day when the startups present their companies to a carefully selected, invite-only audience.

Y Combinator

TiE Angels was launched in July 2010. It is an angel investment group formed by Charter Members of TiE Silicon Valley. The mission of TiE Angels is to support top-tier emerging companies with early stage investment and support.  Since founding TiE Angels in Silicon Valley, the forum has been launched at TiE chapters in other cities including Boston, New York City, Seattle, Portland, and Atlanta.

TiE Angels

SpringTide is a venture capital that provides investment in the health tech industry. The firm was founded in 2018 and is headquartered in Cambridge, Massachusetts, United States.

SpringTide Ventures

The Indian startup scene is set to explode over the next decade. The country with an abundant pool of world class technology talent also has access to one of the most diverse and fast growing home markets. There is also a very strong India-US technology corridor with strong exchanges in technology, people and expertise. This has created a goldilocks moment in India's startup ecosystem. Z21 Ventures Fund will aim to focus and provide value to both the startups and investors.  Z21 Ventures Fund will aim to create a large pool of seed funded technology startups who are ready to disrupt various sectors across the world. The goal would be to identify early stage technology companies and invest in them.

Z21 Ventures

Fireside Ventures is proposing a New Approach to Investing in Consumer Brands. Fireside Ventures invests in early stage consumer brands.

Fireside Ventures

IKP Knowledge Park is an Indian science and technology park that fosters business-driven research and development in life sciences and related fields. It has a mix of ready-to-use multi-tenanted modular wet laboratory blocks with in-built shared facilities and support services, as well as developed land for customized R&D facilities. The operations and maintenance of IKP Knowledge Park is ISO 9001-2008 certified.IKP provides a range of infrastructure services, including electricity, telecommunication, refuse disposal, conference facility, meeting rooms, cafeteria, and gymnasium. Professional agencies take care of common services such as round-the-clock utility maintenance, IT administration, surveillance and security, doctor’s services, housekeeping, and landscape maintenance. The administrative support services include customs clearance, environmental clearances, legal counseling, assistance in getting venture funding, S&T advisory services, liaisoning with government departments, secretarial services, and more. Some key analytical facilities such as a 300 MHz NMR, LCMS, HPLC, GC, FTIR, and Polarimeter are also available at IKP.IKP provides startups with mentoring, funding support, and shared infrastructure in its DST supported incubator; SMEs with wet lab spaces, shared infrastructure, and operational support; and large companies and MNCs with developed land on long-term lease to construct their R&D facilities. Its other activities include technology licensing and intellectual property consulting, research into innovation ecosystems, and research management practices.IKP Knowledge Park was founded by [ICICI Bank Ltd.](https://www.crunchbase.com/organization/icici-bank) in partnership with the Government of Andhra Pradesh in 1999 and is based in Genome Valley, Hyderabad with presence in Secunderabad.

IKP Knowledge Park

Inito

Inito is a developer of a medical testing device designed to facilitate accurate fertility monitoring.

Inito has developed Inito Fertility Monitor, a device that tracks fertility hormones. The company claims to have over 20,000 users and the largest dataset of fertility hormones globally. Inito measures the levels of Estrogen &amp; LH to predict up to 6 fertile days of a woman’s ovulation cycle when there is the highest possibilities of conception. The device also measures Progesterone metabolite PdG, in addition to LH and Estrogen and generates results such as high fertility, peak fertility or ovulation confirmed.

Long-term demographic changes are finally bringing fertility technologies into focus.

Fertility Tech

Fertility monitor app Inito raised $6 M Series A funding from Fireside

Inito has developed Inito Fertility Monitor, a device that tracks fertility hormones. The company claims to have over 20,000 users and the largest dataset of fertility hormones globally. Inito measures the levels of Estrogen &amp; LH to predict up to 6 fertile days of a woman’s ovulation cycle when there is the highest possibilities of conception. The device also measures Progesterone metabolite PdG, in addition to LH and Estrogen and generates results such as high fertility, peak fertility or ovulation confirmed. Further, Inito produces charts and measures actual values of all three hormones and personalizes results to the user. It is claimed to be the only test that measures Estrogen, LH &amp; Progesterone metabolite PdG, and FSH on the same test strip. Funding and financials In November 2023, Initoraised USD 6 million in Series A funding led by Fireside Ventures. The funds were expected to be used to build advanced analytics capabilities with the help of AI.

<div>
 
 Glow offers apps that track data related to women’s fertility including ovulation cycle and pregnancy tracking. In addition to apps, the company also offers individualized fertility coaching, clinic identification and community support, and links patients with clinics for procedures such as egg freezing. 
 
 
 Glow generated around USD 0.3 million monthly revenue in October 2020, and as of February 2019 it had around 15 million users, and claims to have helped about 950,000 women get pregnant (from May 2013 to February 2019). In February 2019 Glow partnered with US Match Group (provider of dating products such as Match.com and Tinder), to provide Match’s employees with egg freezing benefits at reputed fertility clinics. In May 2017 it partnered with the National Institute of Health (NIH) to update a prediction model for couples trying to conceive.  
 
 
 In 2020, the company faced investigations into privacy and security failures involving its app. Glow agreed to pay a USD 0.25 million settlement in September 2020.
 
 
 
</div>

Glow

<div>
 
 Inne, based in Germany, offers an at-home mini lab kit for women. Hormone analysis is conducted based on saliva samples. The lab device connects to smartphones for storage and access to the analysis results.
 
 
 Unlike peer offerings, Inne does not attempt to predict future cycles and fertility dates, and instead educates users about their bodies, with information on what changes they should feel in response to the hormonal levels on the day.
 
 
 In May 2022, Inne 
 <a href="https://sp-edge.com/updates/10667?industryIds=40">
 raised USD 10 million
 </a>
 in an extension to its Series A round led by DSM Venturing. The company utilized the funds to continue the development of its mini lab and platform, grow its team, and support its expansion across the US, where it aims to enter with its perimenopause feature, followed by an expanded product launch in late 2022.
 
 
 
</div>

Inne

Proov (formerly known as MFB Fertility) offers the at-home “Proov'' ovulation and progesterone test. Proov tracks hormone levels in urine over multiple days, after suspected ovulation, and estimates whether the progesterone levels are sufficient for implantation, during the 7-10 day implantation window.As of May 2021, it was the only FDA-cleared urine PdG (urine metabolite of the progesterone hormone) test, and its method of determining the fertile window was patented. Moreover, it received the CE marking and expanded its sales footprint to Europe in June 2021.In June 2020, the company received a USD 1.3 million deal from the US Air Force, to provide Proov kits to enrolled individuals. The Proov test was distributed through leading US retailers such as Target and Amazon, and was also used by doctors across the country.Proov raised USD 9.7 million in Series A funding in December 2021, in a round led by Hambrecht Ducera Growth Ventures, with participation from other venture capital firms such as SteelSky Ventures, WCC Partners, and Lightship Capital, among others. The company expects to use the funding to grow its “Complete” product, which includes follicle-stimulating hormone tests and other multi-hormone tests that measure estrone glucuronide, LH and PdG.

Proov

<div>
 
 Progyny works with employers (primarily large enterprises in the US) to optimize the fertility benefits they offer for their employees. It connects employees to fertility specialists and clinics, and also offers extensive support to patients through their Progyny Patient Care Advocates, who provide clinical guidance, education, and emotional support.
 
 
 The company was founded as a fertility education platform and eventually included in vitro fertilization (IVF) referral network Fertility Authority and reproductive health company Auxogyn, into its network. The company pivoted into offering fertility benefit solutions in 2016, and launched Progyny Rx (fertility medication benefit) in 2018.
 
 
 Progyny connects patients to a network of 800 fertility specialists and nearly 600 clinic locations.&nbsp;
 
 
 Key customers and partnerships
 
 
 As of March 2022, the company served 264 enterprise customers (including Facebook, Microsoft, Google, and Nasdaq), and had 3.9 million active members.
 
 
 Funding and financials
 
 
 In October 2019, Progyny raised USD 130 million through its IPO, where it was listed on the Nasdaq.
 
 
 In FY2021, the company reported a revenue of USD 500.6 million reflecting a 45% YoY growth and a net income of USD 65.8 million. The company&rsquo;s revenue for 
 <a href="https://sp-edge.com/updates/14396">
 Q3 FY2022
 </a>
 amounted to USD 205.4 million, representing 68% YoY growth. The management&rsquo;s revenue guidance for FY2022 ranges between USD 775 million and USD 785 million, which implies an YoY growth of 55% to 57%.
 
</div>

Progyny

<div>
 
 Prima Temp offers the artificial intelligence (AI) assisted “Priya” intarvaginal ring sensor and accompanying app to continuously measure a woman’s core body temperature, predicting fertility windows. The app uses big data to improve its predictions, and the app notifies the user of fertile windows. The company also offers the “Kindara” fertility tracking app, which provides fertility related education and links users to a community of over 140,000 members.  
 
 
 The company raised USD 5 million in funding in May 2019 from Gedeon Richter, a Hungarian pharmaceutical company. Although the company primarily focuses on fertility monitoring, it intends to expand its offerings to include other areas of fertility management such as contraception and menopause.  
 
 
 
 
 
</div>

Prima Temp

Test kits which use saliva, blood, or temperature to determine hormone levels and form conclusions on fertility and fertility cycles.


Apps which use data science to identify fertility windows.

Organizations that freeze eggs or embryos for usage at a future date.


Services that analyze sperm samples (via test kit) and/or offer storage facilities for future use.

Companies specializing in supporting patient decision making, financing, clinical visits, physician referrals, and at-home treatments

Offers digital platforms and apps to provide fertility-related support

Uses AI/ML to improve cycle predictions and track symptoms

Some startups use genetic screening to tailor treatment or identify underlying issues

<div>
 
 <ul>
 <li>Initox has raised USD 6 million in Series A funding led by Fireside Ventures. The funds are expected to be used to build advanced analytics capabilities with the help of AI.</li>
 <li>California-based Inito's home fertility monitoring kit is designed to track estrogen, LH, progesterone metabolite PdG and FSH on a single test strip, reportedly providing a fuller picture of a woman's fertility window. It is claimed that Inito provides numerical values of fertility hormones and personalizes results as well as confirm if the user actually ovulates by looking at the rise in progesterone metabolite PdG.</li>
 </ul>
 
</div>

Inito

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless